Shin W. Kang
InvestorChief Scientific Officer at HEALTHCARE ROYALTY PARTNERS
About
Shin W. Kang serves as Chief Scientific Officer and Head of Research at HCRx, where he leads research efforts and sourcing tied to universities, research institutions, and inventors, having joined in 2015. Before HCRx, he was a vice president of equity research covering biotechnology at Wells Fargo Securities and previously handled technology, intellectual property, and business development at the Mount Sinai School of Medicine. He holds a PhD in Biological Chemistry/Immunology from UCLA, an MBA from Columbia Business School, and a BS from UC Davis, and completed a postdoctoral fellowship at Genentech.
Invests in
Biotech
Colleagues at HEALTHCARE ROYALTY PARTNERS
Aaron B. Simon
Associate at HEALTHCARE ROYALTY PARTNERS
Amy J. Zacharias
Senior Vice President and Controller at HEALTHCARE ROYALTY PARTNERS
Andrew Logerfo
Vice President at HEALTHCARE ROYALTY PARTNERS
Carlos M. Almodóvar
Chief Business Officer at HEALTHCARE ROYALTY PARTNERS
Christopher A. White
President and Chief Financial Officer at HEALTHCARE ROYALTY PARTNERS
Clarke B. Futch
Chairman and Chief Executive Officer at HEALTHCARE ROYALTY PARTNERS
David Oron
Analyst at HEALTHCARE ROYALTY PARTNERS
Eric Yoo
Vice President, PharmD at HEALTHCARE ROYALTY PARTNERS
Frequently asked questions
- Who is Shin W. Kang?
- Shin W. Kang serves as Chief Scientific Officer and Head of Research at HCRx, where he leads research efforts and sourcing tied to universities, research institutions, and inventors, having joined in 2015. Before HCRx, he was a vice president of equity research covering biotechnology at Wells Fargo Securities and previously handled technology, intellectual property, and business development at the Mount Sinai School of Medicine. He holds a PhD in Biological Chemistry/Immunology from UCLA, an MBA from Columbia Business School, and a BS from UC Davis, and completed a postdoctoral fellowship at Genentech.
- Where does Shin W. Kang work?
- Shin W. Kang is Chief Scientific Officer at HEALTHCARE ROYALTY PARTNERS.
- What does Shin W. Kang invest in?
- Shin W. Kang invests in Biotech.